Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Ультразвук-ассистированная оценка толщины висцеральной и подкожной жировой ткани.

Литература/References

  1. Koenen M, Hill MA, Cohen P, et al. Obesity, Adipose Tissue and Vascular Dysfunction. Circ Res. 2021;128(7):951-68. doi:10.1161/ CIRCRESAHA.121.318093.
  2. Mead E, Brown T, Rees K, et al. Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years. Cochrane Database Syst Rev. 2017;6:CD012651. doi:10.1002/14651858.CD012651.
  3. Stefan N, Häring H-U, Hu FB, et al. Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1:152-62. doi:10.1016/S2213-8587(13)70062-7.
  4. Samorodskaya IV. Body mass index and the obesity paradox. Russian Medical Journal. 2014;2:170. (In Russ.) Самородская И. В. Индекс массы тела и парадокс ожирения. Русский медицинский журнал. 2014;2:170.
  5. Doyle SL, Donohoe CL, Lysaght J, et al. Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc Nutr Soc. 2012;71:181-9. doi:10.1017/S002966511100320X.
  6. Britton KA, Massaro JM, Murabito JM, et al. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol. 2013;62:921-5. doi:10.1016/j.jacc.2013.06.027.
  7. Thomas EL, Frost G, Taylor-Robinson SD, et al. Excess body fat in obese and normal-weight subjects. Nutr Res Rev. 2012;25:150-61. doi:10.1017/S0954422412000054. жизни, питания, физической активности и медикаментозной терапии.
  8. Drapkina OM, Kim OT. Epigenetics of obesity. Cardiovascular Therapy and Prevention. 2020;19(6):2632. (In Russ.) Драпкина О. М., Ким О. Т. Эпигенетика ожирения. Кардиоваскулярная терапия и профилактика. 2020;19(6):2632. doi:10.15829/1728-8800-2020-2632.
  9. Yengo L, Sidorenko J, Kemper KE, et al. Meta-analysis of genome-wide association studies for height and body mass index in ~700000 individuals of European ancestry. Hum Mol Genet. 2018;27(20):3641-9. doi:10.1093/hmg/ddy271.
  10. Lapidus L, Bengtsson C, Larsson B, et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenberg, Sweden. Br Med J. 1984;289:1257-61. doi:10.1136/ bmj.289.6454.1257.
  11. Larsson B, Svardsudd K, Welin L, et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. BMJ. 1984;288:1401-4. doi:10.1136/ bmj.288.6428.1401.
  12. Thomas EL, Fitzpatrick JA, Malik SJ, et al. Whole body fat: content and distribution. Prog Nucl Magn Reson Spectrosc. 2013;73:56-80. doi:10.1016/j.pnmrs.2013.04.001.
  13. Matsuzawa Y, Funahashi T, Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb. 2011;18:629-39. doi:10.5551/jat.7922.
  14. Aung KK, Lorenzo C, Hinojosa MA, Haffner SM. Risk of Developing Diabetes and Cardiovascular Disease in Metabolically Unhealthy Normal-Weight and Metabolically Healthy Obese Individuals. J. Clin. Endocrinol. & Metabolism. 2013:2013-832.
  15. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr. 1956;4:20-34. doi:10.1093/ajcn/4.1.20.
  16. Krotkiewski M, Björntorp P, Sjöström L, et al. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest. 1983;72:1150-62. doi:10.1172/ JCI111040.
  17. Ohlson LO, Larsson B, Svardsudd K, et al. The influence of body fat distribution on the incidence of diabetes mellitus. 135 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985;34:1055-8. doi:10.2337/diab.34.10.1055.
  18. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography. Int J Obes. 1983;7:437-45.
  19. Ramos-Lopez O, Riezu-Boj JI, Milagro FI, et al. Prediction of Blood Lipid Phenotypes Using Obesity-Related Genetic Polymorphisms and Lifestyle Data in Subjects with Excessive Body Weight. Int J Genomics. 2018;2018:4283078. doi:10.1155/2018/4283078.
  20. Chaston TB, Dixon JB. Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes. 2008;32:619-28. doi:10.1038/sj.ijo.0803761.
  21. Mahabadi AA, Massaro JM, Rosito GA, et al. Association of pericardial fat, intrathoracic fat, visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J. 2009;30:850-6. doi:10.1093/eurheartj/ehn573.
  22. Ludescher B, Machann J, Eschweiler GW, et al. Correlation of fat distribution in whole body MRI with generally used anthropometric data. Invest Radiol. 2009;44:712-9. doi:10.1097/ RLI.0b013e3181afbb1e.
  23. Kullberg J, Brandberg J, Angelhed JE, et al. Whole-body adipose tissue analysis: comparison of MRI, CT, and dual energy X-ray absorptiometry. Br J Radiol. 2009;82:123-30. doi:10.1259/bjr/ 80083156.
  24. Silver HJ, Niswender KD, Kullberg J, et al. Comparison of gross body fat-water magnetic resonance imaging at 3 Tesla to dual-energy X-ray absorptiometry in obese women. Obesity (Silver Spring). 2013;21:765-74. doi:10.1002/oby.20287.
  25. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition. 2004;92(3):347-55. doi:10.1079/bjn20041213.
  26. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39-48. doi:10.1161/CIRCULATIONAHA.106.675355.
  27. Nakanishi K, Fukuda S, Tanaka A, et al. Relationships between periventricular epicardial adipose tissue accumulation, coronary microcirculation, and left ventricular diastolic dysfunction. The Canadian Journal of Cardiology. 2017;33(11):1489-97. doi:10.1016/j.cjca.2017.08.001.
  28. Kossaify A, Nicolas N. Impact of overweight and obesity on left ventricular diastolic function and value of tissue Doppler echocardiography. Clinical Medicine Insights. Cardiology. 2013;7:43-50. doi:10.4137/CMC.S11156.
  29. Negi SI, Jeong EM, Shukrullah I, et al. Association of low plasma adiponectin with early diastolic dysfunction. Congestive Heart Failure (Greenwich, Conn.). 2011;18(4):187-91. doi:10.1111/j.1751-7133.2011.00276.x.
  30. Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. Journal of the American College of Cardiology. 2008;51(1):1-11. doi:10.1016/j.jacc.2007.09.026.
  31. Bailey GW, Braniff BA, Hancock EW, Cohn KE. Relation of left atrial pathology to atrial fibrillation in mitral valvular disease. Annals of Internal Medicine. 1968;69(1):13-20. doi:10.7326/0003-4819-69-1-13.
  32. Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation. 1976;53(2):273-9. doi:10.1161/01. cir.53.2.273.
  33. Ionin VA, Zaslavskaya EL, Barashkova EI, et al. Predictors of atrial fibrillation recurrence in patients with metabolic syndrome after pulmonary vein isolation. Russian Journal of Cardiology. 2022;27(3S):5184. (In Russ.) Ионин В. А., Заславская Е. Л., Барашкова Е. И. и др. Предикторы рецидива фибрилляции предсердий у пациентов с метаболическим синдромом после радиочастотной изоляции устьев легочных вен. Российский кардиологический журнал. 2022;27(3S):5184. doi:10.15829/1560-4071-2022-5184.
  34. Chumakova GA, Gritsenko OV, Gruzdeva OV, Zateev AV. Predicting the risk of left ventricular diastolic dysfunction in obesity. Russian Journal of Cardiology. 2022;27(4):4811. (In Russ.) Чумакова Г. А., Гриценко О. В., Груздева О. В., Затеев А. В. Прогнозирование риска развития диастолической дисфункции левого желудочка при ожирении. Российский кардиологический журнал. 2022;27(4):4811. doi:10.15829/1560-4071-2022-4811.
  35. Druzhilov MA, Kuznetsova TYu. Epicardial adiposity as a predictor of COVID-19 severity in overweight and obese patients. Russian Journal of Cardiology. 2022;27(3):4850. (In Russ.) Дружилов М. А., Кузнецова Т. Ю. Эпикардиальное висцеральное ожирение как предиктор тяжести течения COVID-19 у пациентов с избыточным весом и ожирением. Российский кардиологический журнал. 2022;27(3):4850. doi:10.15829/1560-4071-2022-4850.
  36. Le Jemtel TH, Samson R, Ayinapudi K, et al. Epicardial adipose tissue and cardiovascular disease. Current Hypertension Reports. 2019;21(5):36. doi:10.1007/s11906-019-0939-6.
  37. Chumakova GA, Veselovskaya NG. Methods of visceral obesity assessment in clinical practice. Russian Journal of Cardiology. 2016;(4):89-96. (In Russ.) Чумакова Г. А., Веселовская Н. Г. Методы оценки висцерального ожирения в клинической практике. Российский кардиологический журнал. 2016;(4):89-96. doi:10.15829/1560-4071-2016-4-89-96.
  38. Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292(20):2471-7. doi:10.1001/ jama.292.20.2471.
  39. Ansaldo AM, Montecucco F, Sahebkar A, et al. Epicardial adipose tissue and cardiovascular diseases. International journal of Cardiology. 2019;278:254-60. doi:10.1016/j.ijcard.2018.09.089.
  40. Pugliese NR, Paneni F, Mazzola M, et al. Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure. European Journal of Heart Failure. 2021;23(11):1858-71. doi:10.1002/ejhf.2337.
  41. Hendricks S, Dykun I, Balcer B, et al. Epicardial adipose tissue is a robust measure of increased risk of myocardial infarction – a meta-analysis on over 6600 patients and rationale for the EPIC-ACS study. Medicine. 2021;100(52):e28060. doi:10.1097/ MD.0000000000028060.
  42. Fisser C, Colling S, Debl K, et al. The impact of epicardial adipose tissue in patients with acute myocardial infarction. Clinical Research in Cardiology. 2021;10(10):1637-46. doi:10.1007/ s00392-021-01865-4.
  43. Jung ED, Chung DS, Lee J. The correlation between visceral fat distance measured by ultrasonography and visceral fat amount by computed tomography in type 2 diabetes. Korean Diabetes Journal. 2008;32(5):418-27. doi:10.4093/kdj.2008.32.5.418.
  44. Pimanov S, Bondarenko V, Makarenko E. Visceral fat in different locations assessed by ultrasound: Correlation with computed tomography and cut-off values in patients with metabolic syndrome. Clin. Obes. 2020;10(6):e12404. doi:10.1111/cob. 12404.
  45. Mauad FM, Chagas-Neto FA, Benedeti ACGS, et al. Reproducibility of abdominal fat assessment by ultrasound and computed tomography. Radiol. Bras. 2017;50(3):141-7. doi:10.1590/0100-3984.2016.0023.
  46. Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715-25. doi:10.1016/S2213-8587(19)30084-1.
  47. Abergel E, Tase M, Bohlender J, et al. Which definition for echocardiographic left ventricular hypertrophy? American Journal of Cardiology. 1995;75(7):498-502. doi:10.1016/s0002-9149(99)80589-x.
  48. Sugimoto T, Dulgheru R, Bernard A, et al. Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study. European Heart Journal – Cardiovascular Imaging. 2017;18(8):833-40. doi:10.1093/ehjci/ jex140.
  49. Pathan F, D’Elia N, Nolan MT, et al. Normal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysis. Journal of the American Society of Echocardiography. 2017;30(1):59-70.e8. doi:10.1016/j.echo. 2016.09.007.
  50. Vasilkova TN, Balaeva TB, Mataev SI, Rybina YuA. The influence of various types of fat deposition on the state of the cardiovascular system. Heart: A journal for practicing physicians. 2014;13(1):45-9. (In Russ.) Василькова Т. Н., Баклаева Т. Б., Матаев С. И., Рыбина Ю. А. Влияние различных типов жироотложения на состояние сердечно-сосудистой системы. Сердце: Журнал для практикующих врачей. 2014;13(1):45-9. EDN VHFZZL.
  51. Bondarenko VM, Pimanov SI, Makarenko EV. Ultrasound diagnosing of visceral adiposity. Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus Vestnik VGMU. 2017;16(1):71-9. doi:10.22263/2312-4156.2017.1.71.
  52. Hirooka M, Kumagi T, Kurose K, et al. A Technique for the Measurement of Visceral Fat by Ultrasonography: Comparison of Measurements by Ultrasonography and Computed Tomography. Internal Medicine. 2005;44(8):794-9. doi:10.2169/ internalmedicine.44.794.
  53. Drapkina OM, Dzhioeva ON, Balakhonova TV, et al. Ultrasound-assisted examination in internal medicine practice. Cardiovascular Therapy and Prevention. 2023;22(1):3523. (In Russ.) Драпкина О. М., Джиоева О. Н., Балахонова Т. В. и др. Ультразвук-ассистированный осмотр в практике врача-терапевта. Методические рекомендации. Кардиоваскулярная терапия и профилактика. 2023;22(1):3523. doi:10.15829/1728-8800-2023-3523.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

Литература/References
На предыдущую главу Предыдущая глава
оглавление
Следующая глава

Table of contents

Данный блок поддерживает скрол*